KOSDAQ - Delayed Quote KRW
Englewood Lab, Inc. (950140.KQ)
At close: November 15 at 3:30 PM GMT+9
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
210,191,926.00
206,784,099.00
151,508,766.00
160,816,441.00
137,168,122.00
Cost of Revenue
161,791,177.00
158,997,238.00
125,655,222.00
126,316,291.00
112,015,209.00
Gross Profit
48,400,749.00
47,786,861.00
25,853,544.00
34,500,150.00
25,152,913.00
Operating Expense
20,352,420.00
18,931,752.00
15,971,992.00
17,548,069.00
17,283,590.00
Operating Income
28,048,329.00
28,855,109.00
9,881,552.00
16,952,081.00
7,869,323.00
Net Non Operating Interest Income Expense
-174,900.00
-480,884.00
-965,253.00
-736,260.00
-905,727.00
Pretax Income
31,064,028.00
28,715,378.00
8,352,970.00
15,098,065.00
4,801,341.00
Tax Provision
8,736,445.00
7,972,947.00
1,087,553.00
100,742.00
1,719,480.00
Net Income Common Stockholders
22,327,582.00
20,742,431.00
7,265,416.00
14,997,323.00
3,081,861.00
Basic EPS
1.12k
1.04k
362.00
755.00
153.00
Diluted EPS
1.12k
1.04k
362.00
755.00
153.00
Basic Average Shares
19,960.81
19,868.23
20,070.21
19,864.00
20,142.88
Diluted Average Shares
19,960.81
19,868.23
20,070.21
19,864.00
20,142.88
Total Operating Income as Reported
28,048,328.00
28,855,109.00
9,881,551.00
16,952,079.00
7,869,323.00
Rent Expense Supplemental
26,288.00
20,392.00
18,640.00
16,826.00
29,388.00
Total Expenses
182,143,597.00
177,928,990.00
141,627,214.00
143,864,360.00
129,298,799.00
Net Income from Continuing & Discontinued Operation
22,327,582.00
20,742,431.00
7,265,416.00
14,997,323.00
3,081,861.00
Normalized Income
22,303,768.76
20,513,896.70
7,874,145.84
16,820,905.39
3,930,363.33
Interest Income
424,905.00
218,045.00
12,106.00
7,756.00
1,949.00
Interest Expense
599,808.00
698,930.00
977,358.00
741,099.00
976,238.00
Net Interest Income
-174,900.00
-480,884.00
-965,253.00
-736,260.00
-905,727.00
EBIT
31,663,836.00
29,414,308.00
9,330,328.00
15,839,164.00
5,777,579.00
EBITDA
36,225,656.00
33,807,886.00
13,678,869.00
20,143,357.00
10,215,665.00
Reconciled Cost of Revenue
161,791,177.00
158,997,238.00
125,655,222.00
126,316,291.00
112,015,209.00
Reconciled Depreciation
4,561,820.00
4,393,578.00
4,348,541.00
4,304,193.00
4,438,086.00
Net Income from Continuing Operation Net Minority Interest
22,327,582.00
20,742,431.00
7,265,416.00
14,997,323.00
3,081,861.00
Total Unusual Items Excluding Goodwill
33,131.00
316,378.00
-699,850.00
-1,835,832.00
-1,321,912.00
Total Unusual Items
33,131.00
316,378.00
-699,850.00
-1,835,832.00
-1,321,912.00
Normalized EBITDA
36,192,525.00
33,491,508.00
14,378,719.00
21,979,189.00
11,537,577.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
9,317.76
87,843.70
-91,120.16
-12,249.61
-473,409.67
12/31/2020 - 10/14/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade